IXELLES PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IXELLES PHARMA
Largest movements
- Receivables within one year -€96,509
down €96,509 (-29.3%), from €329,585 to €233,076
of which Other amounts receivable: -€122,193
- Stocks and contracts +€35,764
up €35,764 (+19.2%), from €186,321 to €222,085
- Deferred charges and accrued income +€12,787
up €12,787 (+19,180%), from €67 to €12,854
- Debts after one year -€203,434
no longer reported in 2025 (was €203,434)
- Other debts +€173,262
up €173,262 (+754%), from €22,978 to €196,241
- Reserves -€53,000
down €53,000 (-94.7%), from €55,960 to €2,960
- Profit (loss) carried forward +€31,115
up €31,115 (+5.7%), from €543,742 to €574,857
- Trade debts +€25,832
up €25,832 (+13.2%), from €196,226 to €222,059
- Staff costs +€13,807
up €13,807 (+20.8%), from €66,394 to €80,200
- Gross operating margin -€5,472
down €5,472 (-3.3%), from €166,476 to €161,004
- Financial charges -€3,739
down €3,739 (-13.1%), from €28,441 to €24,702
- Taxes -€3,717
down €3,717 (-25.5%), from €14,574 to €10,857
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,077,193 | €1,028,716 | -€48,477 | -4.5% |
| Fixed assets | 21/28 | €256,745 | €246,786 | -€9,959 | -3.9% |
| Tangible fixed assets | 22/27 | €256,520 | €246,561 | -€9,959 | -3.9% |
| Land and buildings | 22 | €239,158 | €228,773 | -€10,385 | -4.3% |
| Plant, machinery and equipment | 23 | €14,188 | €15,838 | +€1,650 | +11.6% |
| Furniture and vehicles | 24 | €3,174 | €1,949 | -€1,225 | -38.6% |
| Financial fixed assets | 28 | €225 | €225 | = | 0.0% |
| Current assets | 29/58 | €820,447 | €781,930 | -€38,518 | -4.7% |
| Stocks and contracts in progress | 3 | €186,321 | €222,085 | +€35,764 | +19.2% |
| Stocks | 30/36 | €186,321 | €222,085 | +€35,764 | +19.2% |
| Amounts receivable within one year | 40/41 | €329,585 | €233,076 | -€96,509 | -29.3% |
| Trade receivables | 40 | €171,704 | €197,388 | +€25,684 | +15.0% |
| Other amounts receivable | 41 | €157,881 | €35,688 | -€122,193 | -77.4% |
| Cash at bank and in hand | 54/58 | €304,475 | €313,915 | +€9,440 | +3.1% |
| Deferred charges and accrued income | 490/1 | €67 | €12,854 | +€12,787 | +19,180% |
| Total equity and liabilities | 10/49 | €1,077,193 | €1,028,716 | -€48,477 | -4.5% |
| Equity | 10/15 | €615,769 | €593,884 | -€21,885 | -3.6% |
| Contributions | 10/11 | €16,067 | €16,067 | = | 0.0% |
| Reserves | 13 | €55,960 | €2,960 | -€53,000 | -94.7% |
| Distributable reserves | 133 | €55,960 | €2,960 | -€53,000 | -94.7% |
| Profit (loss) carried forward | 14 | €543,742 | €574,857 | +€31,115 | +5.7% |
| Amounts payable | 17/49 | €461,424 | €434,832 | -€26,592 | -5.8% |
| Amounts payable after more than one year | 17 | €203,434 | - | -€203,434 | |
| Financial debts | 170/4 | €203,434 | - | -€203,434 | |
| Amounts payable within one year | 42/48 | €256,966 | €434,832 | +€177,865 | +69.2% |
| Current portion of amounts payable after more than one year | 42 | €22,985 | - | -€22,985 | |
| Trade debts | 44 | €196,226 | €222,059 | +€25,832 | +13.2% |
| Suppliers | 440/4 | €196,226 | €222,059 | +€25,832 | +13.2% |
| Taxes, remuneration and social security | 45 | €14,777 | €16,532 | +€1,755 | +11.9% |
| Taxes | 450/3 | €2,551 | €1,748 | -€803 | -31.5% |
| Remuneration and social security | 454/9 | €12,226 | €14,785 | +€2,559 | +20.9% |
| Other amounts payable | 47/48 | €22,978 | €196,241 | +€173,262 | +754% |
| Accrued charges and deferred income | 492/3 | €1,024 | - | -€1,024 | |
| Remuneration, social security and pensions | 62 | €66,394 | €80,200 | +€13,807 | +20.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,583 | €14,129 | -€454 | -3.1% |
| Other operating charges | 640/8 | €4 | - | -€4 | |
| Gross operating margin | 9900 | €166,476 | €161,004 | -€5,472 | -3.3% |
| Operating profit (loss) | 9901 | €85,496 | €66,674 | -€18,821 | -22.0% |
| Financial charges | 65/66B | €28,441 | €24,702 | -€3,739 | -13.1% |
| Recurring financial charges | 65 | €28,441 | €24,702 | -€3,739 | -13.1% |
| Profit (loss) for the period before taxes | 9903 | €57,054 | €41,972 | -€15,082 | -26.4% |
| Income taxes | 67/77 | €14,574 | €10,857 | -€3,717 | -25.5% |
| Profit (loss) for the period | 9904 | €42,481 | €31,115 | -€11,365 | -26.8% |
| Profit (loss) for the period to be appropriated | 9905 | €42,481 | €31,115 | -€11,365 | -26.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.